A large selection of RZHRG’s publications are listed below. Please note that they are organized by date (1986 to present). A search on Medline, OVID or Google will generate further results.

Seminars and Course Presentations:

• "HIV in African Couples", presentation by Dr. Allen at the Emory Center for AIDS Research Evening Soiree, September 21 2005

• "Running HIV Research Programs in Africa: Logistical and Management Aspects", presentation by Dr. Allen at the Department of Global Health Wednesday Seminar Series, September 07 2005

Conference Abstracts and Presentations:

• AIDS Vaccine 2006 Conference, August/September 2006, Amsterdam, The Netherlands: posters, abstracts, and presentations: "Gp41 HMA as a screening tool to study HIV transmission between partners", presented by Olivier Manigart, and "Recruiting HIV Discordant Couples for Vaccine Trials Through Couples' Voluntary Counseling and Testing Centers in Lusaka, Zambia", presented by Cheswa Vwalika.

• AIDS 2006 XVI International AIDS Conference, August 2006, Toronto, Canada: posters and abstracts

• "Primary Causes of Mortality in HIV Discordant Zambian Couples", presentation by Phil Peters MD at the Conference on Retroviruses and Opportunistic Infections, February 2006, Denver, USA.

• "Recruitment and retention of an HIV discordant couple cohort in Kigali, Rwanda in preparation for vaccine efficacy trials", presentation by Erin Shutes MPH at the AIDS Vaccine Conference,  September 2005, Montreal, Canada

• AIDS Vaccine Conference,  September 2005, Montreal, Canada: posters and abstracts

• International AIDS Society Conference on Pathogenesis and Treatment, July 2005, Rio de Janeiro, Brazil: posters and abstracts

• AIDS Vaccine International Conference, August 2004, Lausanne, Switzerland. "Pre-screening for low risk, healthy phase I HIV vaccine trial participants in Kigali, Rwanda" presentation by Erin Shutes, MPH

• "Improving on a Successful Model for Promoting Couples' VCT in Two African Capitals: Mobile Couples' HIV Testing Units", presentation by Dvorah Joseph, MPH at the XV International AIDS Conference, July 2004, Bangkok, Thailand. 

Additional links:

• Emory’s Center for AIDS Research (CFAR): www.sph.emory.edu/CFAR

• National Institutes of Health (NIH): www.nih.gov

• International AIDS Vaccine Initiative: www.iavi.org

• Bill and Melinda Gates Foundation: www.gatesfoundation.org

• Centers for Disease Control and Prevention: www.cdc.gov

Publications

1. Schwartz ND, So YT, Hollander H, Allen S, Fye KH. Eosinophilic vasculitis leading to amaurosis fugax in a patient with acquired immunodeficiency syndrome. Arch Intern Med 1986;146(10):2059-60.

2. Keene WE, Petitt MG, Allen S, McKerrow JH. The major neutral proteinase of Entamoeba histolytica. JEM 1986;163(3):536-49.

3. Van de Perre P, Nzaramba D, Allen S, Riggin CH, Sprecher-Goldberger S, Butzler JP. Comparison of six serological assays for human immunodeficiency virus antibody detection in developing countries. J Clin Microbiol 1988;26(3):552-6.

4. Pagliuca A, Layton DM, Allen S, Mufti GJ. Hyperinfection with strongyloides after treatment for adult T cell leukaemia-lymphoma in an African immigrant. BMJ 1988;297(6661):1456-7.

5. Carael M, Van de Perre PH, Lepage PH, Allen S, Nsengumuremyi F, Van Goethem C, Ntahorutaba M, Nzaramba D, Clumeck N. Human immunodeficiency virus transmission among heterosexual couples in Central Africa. AIDS 1988;2(3):201-5.

6. Lepage P, van de Perre P, Dabis F, Commenges D, Orbinski J, Hitimana DG, Bazubagira A, Van Goethem C, Allen S, Butzler JP, Nsengumuremyi F.  Evaluation and simplification of the World Health Organization clinical case definition for paediatric AIDS. AIDS 1989;3(4):221-5.

7. Bogaerts J, Verhaegen J, Martinez Tello W, Allen S, Verbist, van Dyck E, Piot P.  Characterization, in vitro susceptibility, and clinical significance of CDC group HB-5 from Rwanda. J Clin Microbiol 1990;28(10):2196-9.

8. Allen S, Van de Perre P, Serufilira A, Lepage P, Carael M, DeClercq A, Tice J, Black D, Nsengumuremyi F, Ziegler J, Levy J, Hulley S. Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda. J Infect Dis 1991;164(1):67-71.

9. Allen S, Lindan C, Serufilira A, Van de Perre P, Rundle AC, Nsengumuremyi F, Carael M, Schwalbe J, Hulley S. Human immunodeficiency virus infection in urban Rwanda. Demographic and behavioral correlates in a representative sample of childbearing women. JAMA 1991;266(12):1657-63.

10. Lindan C, Allen S, Carael M, Nsengumuremyi F, Van de Perre P, Serufilira A, Tice J, Black D, Coates T, Hulley S. Knowledge, attitudes, and perceived risk of AIDS among urban Rwandan women: relationship to HIV infection and behavior change [published erratum appears in AIDS 1992 Jan;6(1):128]. AIDS 1991;5(8):993-1002.

11. Taelman H, Batungwanayo J, Clerinx J, Kagame A, Bogaerts, J, Allen S, Van de Perre P. Tuberculosis and HIV infection [letter; comment]. BMJ 1991;302(6786):1206.

12. Taelman H, Batungwanayo J, Clerinx J, Kagame A, Bogaerts J, Allen S, van de Perre P.  Risk of tuberculosis among women of childbearing age with HIV infection in Zaire [letter; comment]. Am Rev Respir Dis 1991;144(5):1219-20.

13. King R, Van de Perre P, Allen S, Serufilira A, Homsy J. Predictive value of indeterminate HIV western blot [letter]. Lancet 1991;338(8777):1278.

14. Batungwanayo J, Taelman H, Dhote R, Bogaerts J, Allen S, Van de Perre P. Pulmonary tuberculosis in Kigali, Rwanda. Impact of human immunodeficiency virus infection on clinical and radiographic presentation. Am Rev Respir Dis 1992;146(1):53-6.

15. Allen S, Batungwanayo J, Kerlikowske K, Lifson AR, Wolf W, Granich R, Taelman H, Van de Perre P, Serufilira A, Bogaerts J, Slutkin G, Hopewell PC. Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am Rev Respir Dis 1992;146(6):1439-44.

16. Taelman H, Batungwanayo J, Clerinx J, Kagame A, Bogaerts J, Allen S, Van de Perre P. Tuberculous meningitis in patients infected with the human immunodeficiency virus [letter; comment]. N Engl J Med 1992;327(16):1171; discussion 1171-2.

17. Allen S, Serufilira A, Bogaerts J, Van de Perre P, Nsengumuremyi F, Lindan C, Carael M, Wolf W, Coates T, Hulley S. Confidential HIV testing and condom promotion in Africa. Impact on HIV and gonorrhea rates. JAMA 1992;268(23):3338-43.

18. Allen S, Tice J, Van de Perre P, Serufilira A, Hudes E, Nsengumuremyi F, Bogaerts J, Lindan C, Hulley S. Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ 1992;304(6842):1605-9.

19. Lindan CP, Allen S, Serufilira A, Lifson AR, Van de Perre P, Chen-Rundle A, Batungwanayo J, Nsengumuremyi F, Bogaerts J, Hulley S.  Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med 1992;116(4):320-8.

20. Allen S, Serufilira A, Gruber V, Kegeles S, Van de Perre P, Carael M, Coates T. Pregnancy and contraception use among urban Rwandan women after HIV testing and counseling. Am J Public Health 1993;83(5):705-10.

21. King R, Frey S, Beisha R, Van de Perre P, Karita E, Allen S. The presence or absence of gp120/gp160 bands on indeterminate western blots: predictive value for HIV seroconversion [letter]. AIDS 1993;7(3):437-8.

22. King R, Allen S, Serufilira A, Karita E, Van de Perre P. Voluntary confidential HIV testing for couples in Kigali, Rwanda [letter]. AIDS 1993;7(10):1393-4.

23. Batungwanayo J, Taelman H, Allen S, Bogaerts J, Kagame A, Van de Perre P. Pleural effusion, tuberculosis and HIV-1 infection in Kigali, Rwanda. AIDS 1993;7(1):73-9.

24. Moore PS, Allen S, Sowell AL, Van de Perre P, Huff DL, Serufilira A, Nsengumuremyi F, Hulley SB. Role of nutritional status and weight loss in HIV seroconversion among Rwandan women. JAIDS 1993;6(6):611-6.

25. Keogh P, Allen S, Almedal C, Temahagili B. The social impact of HIV infection on women in Kigali, Rwanda: a prospective study. Soc Sci & Med 1994;38(8):1047-53.

26. King R, Fox E, Twagirakristu JB, Karita E, Allen S. Excess morbidity related to HIV infection. Trans R Soc Trop Med Hyg 1994;88(3):295.

27. Kerlikowske KM, Katz MH, Allen S, Wolf W, Hudes E, Karita E, Serufilira A, Van de Perre P. Beta 2-microglobulin as a predictor of death in HIV-infected women from Kigali, Rwanda. AIDS 1994;8(7):963-9.

28. Batungwanayo J, Taelman H, Bogaerts J, Bogaerts J, Allen S, Lucas S, Kagame A, Clerinx J, Montane J, Saraux A, Muhlberger F, van de Perre P.  Pulmonary cryptococcosis associated with HIV-1 infection in Rwanda: a retrospective study of 37 cases. AIDS 1994;8(9):1271-6.

29. Batungwanayo J, Taelman H, Lucas S, Bogaerts J, Alard D, Kagame A, Balanche P, Clerinx J, van de Perre P, Allen S.  Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology. Am J Respir Crit Care Med 1994;149(6):1591-6.

30. Taelman H, Bogaerts J, Batungwanayo J, Van de Perre P, Lucas S, Allen S. Failure of the cryptococcal serum antigen test to detect primary pulmonary cryptococcosis in patients infected with human immunodeficiency virus [letter]. Clin Infect Dis 1994;18(1):119-20.

31. Lifson AR, Allen S, Wolf W, Serufilira A, Kantarama G, Lindan CP, Hudes ES, Nsengumuremyi F, Taelman H, Batungwanayo J. Classification of HIV infection and disease in women from Rwanda. Evaluation of the World Health Organization HIV staging system and recommended modifications. Ann Intern Med 1995;122(4):262-70.

32. Van der Straten A, King R, Grinstead O, Serufilira A, Allen S. Couple communication, sexual coercion and HIV risk reduction in Kigali, Rwanda [published erratum appears in AIDS 1995 Nov;9(11):following 1298]. AIDS 1995;9(8):935-44.

33. King R, Estey J, Allen S, Kegeles S, Wolf W, Valentine C, Serufilira A. A family planning intervention to reduce vertical transmission of HIV in Rwanda. AIDS 1995;9(Suppl 1):S45-51.

34. Seed J, Allen S, Mertens T, Hudes E, Serufilira A, Carael M, Karita E, Van de Perre P, Nsengumuremyi F. Male circumcision, sexually transmitted disease, and risk of HIV. JAIDS & HR 1995;8(1):83-90.

35. McKenna SL, Muyinda GK, Roth D, Mwali, M, N’gandu, N, Myrick, A., Priddy, FH, Hall, VM, von Lieven, AA, Sabatino, JR, Allen, S. Rapid HIV testing and counseling for voluntary HIV testing centers in Africa. AIDS 1997 Sept 11; Suppl 1: S103-10.

36. Betts MR, Krowka J, Santamaria C, Balsamo K, Gao F, Mulundu G, Luo C, N’Gandu N, Sheppard H, Hahn BH, Allen S, Frelinger JA.  Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lyM.P.H.ocyte responses in HIV-infected Zambians.   J Virol 1997 Nov; 71(11):8908-8911.

37. Tang J, Allen S, Karita E, Musonda R, Kaslow RA.  New TAP2 polymorphisms in Africans.  Tissue Antigens 1998; 51:556-562.

38. Camp WL, Allen S, Alvarez JO, Jolly PE, Weiss HL, Phillips JF, Etienne K, Serufilira A, Vermund SH.  Serum retinol and HIV-1 RNA viral load in rapid and slow progressors.  JAIDS 1998;18:401-406.

39. Van der Straten A, King R, Grinstad O, Vittinghoff E, Serufilira A, Allen S.  Sexual coersion, physical violence, and HIV infection among women in steady relationships in Kigali, Rwanda.  AIDS Behav 1998; 2 (1): 61-73.

40. Tang J, Costello C, Ireneus PMK, Rivers C, LeBlanc S, Karita E, Allen S, Kaslow RA.  HLA Class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection.  AIDS Res Hum Retroviruses 1999; 15(4):317-24.

41. Costello C, Tang J, Rivers C, Karita E, Meizen-Derr J, Allen S, Kaslow RA.  HLA-B*57 independently associated with slower HIV-1 disease progression in Rwandan women.  AIDS 1990; 13(14): 1990 -1.

42. Lartigue K, Kantarama G, Sanstad KH, Binson D, Allen S.  Willingness to participate in Efficacy Trials of HIV Prophylactic Vaccines: Results of focus groups with HIV-Negative Rwandan Women. [UNPUBLISHED].

43. Allen S, Karita E, N’gandu N, Tichacek A.  The evolution of voluntary testing and counseling as an HIV prevention strategy [Book Chapter]. Preventing HIV in Developing Countries: Biomedical and Behavioral Approaches, Gibney et al. Plenum Press, New York, 1999.

44. Bakari J.P., McKenna S, Myrick A, Mwinga K, Bhat G.J., Allen S. Rapid Voluntary Testing and Counseling for HIV: Acceptability and Feasibility in Zambian Antenatal Care Clinics. Ann N Y Acad Sci 2000; 918:64-76

45. Tang J, Freedman DO, Allen S, Karita E, Musonda R, Braga C, Jameison B D, Louie L, Kaslow R. Genotyping TAP2 variants in North American Caucasians, Brazilians and Africans. Genes and Immunity 2001; 2(1), 32-40

46. Tang J, D O Freedman, Allen S, Karita E, Musonda R, Braga C, Margolick J, Kaslow R. TAP 1 Polymorphisms  in several Human ethnic groups: Characteristics, Evolution, and genotyping strategies.  Human Immunology 62, 256-268 (2001)

47. Roth David L, Stewart K, Clay O J, VanDerStraten A, Karita E, Allen S.  Sexual Practices of HIV discordant and concordant couples in Rwanda: effects of a testing and counseling programme for men.  International Journal of STD’s & AIDS 2001; 12 D308.1.8

48. Rodenburg C, Yingying L, Trask S, Chen Y, Decker J, Robertson D, Kalish M, Shaw G, Allen S, Hahn B, Gao F, and the UNAIDS and NIAID Networks for HIV isolation and characterization.  Near Full length clones and reference sequences for Subtype C isolates of HIV type 1 from Three different continents.  AIDS research and Human Retroviruses. Volume 17 Number 2 January 2001

49. Fideli U, Allen S, Musonda R, Trask S, Hahn B, Weiss H, Mulenga J, Kasolo F, Vermund S, Aldrovandi G. Virologic and Immunologic Determinants of Heterosexual Transmission of Human Immunodeficiency Virus Type 1 in Africa.  AIDS Research and Human Retroviruses.  Volume 17, Number 10, 2001, pp. 901-910.

50. Tang J, Naik E, Costello C, Karita E, Rivers C, Allen S, Kaslow R.  Characteristics of HLA Class I & Class II Polymorphisms in Rwandan Women. Experimental & Clinical Immunogenetics. Volume 17: 185-198. 2000.

51. Tang J, Myracle AD, Allen S, Karita E, Musonda R, Fultz PN, Kaslow RA. Novel alleles at the lymphotoxin alpha (LTalpha) locus mark extended HLA haplotypes in native Africans. Hum Immunol 2001,62:269-278.

52. Roman F, Karita E, Monnet A, Lambert C, Fontaine E, Allen S, et al. Rare and new V3 loop variants in HIV-1-positive long-term non-progressors from Rwanda. AIDS 2002,16:1827-1829.

53. Tang J, Tang S, Lobashevsky E, miracle AD, Fideli U, Aldrovandi G, Allen S, et al. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J Virol 2002,76:8276-8284

54. Trask SA, Derdeyn CA, Fideli U, Chen Y, Meleth S, Kasolo F, Musonda R, Hunter E, Gao F, Allen S, Hahn BH. Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia. J Virol 2002,76:397-405.

55. Allen S, Meinzen-Derr J, Kautzman M, et al. Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS 2003,17:733-740.

56. Gao F, Li Y, Decker JM, Peyerl FW, Bibollet-Ruche F, Rodenburg CM, Chen Y, Shaw DR, Allen S, et al. Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice. AIDS Res Hum Retroviruses. Sep 2003;19(9):817-823.

57. Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, Denham SA, Heil ML, Kasolo F, Musonda R, Hahn BH, Shaw GM, Korber BT, Allen S, Hunter E. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science. Mar 26 2004;303(5666):2019-2022.

58. Tang J, Tang S, Lobashevsky E, Zulu I, Aldrovandi G, Allen S, Kaslow RA. HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners. AIDS Res Hum Retroviruses 2004;20(1):19-25.

59. Tang J, Penman-Aguilar A, Lobashevsky E, Allen S, Kaslow RA. HLA-DRB1 and -DQB1 alleles and haplotypes in Zambian couples and their associations with heterosexual transmission of HIV type 1. J Infect Dis. May 1 2004;189(9):1696-1704.

60. Dorak MT, J Tang, A Penman-Aguilar, AO Westfall, I Zulu, ES Lobashevsky, NG Kancheya, MM Schaen, SA Allen, RA Kaslow. Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples. Lancet 2004; 363: 2137-39.

61. Tang J, Rivers C, Karita E, et al. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression. Genes & Immunity 1999, 1:20-27.

62. Hoesley, CJ, Allen SA, Raper JL, et al. Comparative analysis of commercial assays for the detection and quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in plasma from patients infected with HIV-1 subtype C. Clinical Infectious Diseases 2002, 35:323-325.

63. Masemola AM, Mashishi TN, Khoury G, et al. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. Journal of Immunology 2004, 173:4607-4617.

64. Fischer A, Lejczak C, Lambert C, et al. Is the Vpr R77Q mutation associated with long-term non-progression of HIV infection? AIDS 2004, 18:1346-1347.

65. Masemola A, Mashishi T, Khoury G, et al. Hierarchival targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. Journal of Virology 2004, 78:3233-3243.

66. Modjarrad K, Zulu I, Karita E, et al. Predictors of HIV serostatus among HIV discordant couples in Lusaka, Zambia and female antenatal clinic attendants in Kigali, Rwanda. AIDS Research and Human Retroviruses 2005, 21:5-12.

67. Allen S. Why is fertility an issue for HIV-infected and at-risk women? JAIDS 2005, Supplement 1:S1-S3.

68. Allen S. International Data. JAIDS 2005, Volume 38, Supp.1:S7-S8 (Fertility Regulation and Systemic Hormones in HIV-Infected and At-Risk Women, Conference Proceedings).

69. Song, W., Wilson, C.M., Allen, S., Wang, C., Li, Y., Kaslow, R.A., et al. (2006).  Interleukin 18 and human immunodeficiency virus type 1 infection in adolescents and adults.  Clinical and Experimental Immunology, 144(1), 117-124.

70. Johnson, R.W., Li, B., Sunay, S., Moore, R.H., Mulenga, J., Hunter, E., et al. (2006).  Real-time PCR quantitation of subtype C HIV DNA in a Zambian discordant couple cohort.  AIDS Research and Human Retroviruses, 22(5), 438-444.

71. Lazaryan, A., Lobashevsky, E., Mulenga, J., Allen, S., Blackwell, J., Tang, J., et al. (2006).  Human leukocyte antigen B58 supertype and human immodeficiency virus type 1 infection in native Africans.  Journal of Virology, 80(12), 6056-6060.

72. Li, B., Decker, J. M., Johnson, R. W., Bibollet-Ruche, F., Wei, X., Mulenga, J., et al. (2006). Evidence for Potent Autologous Neutralizing Antibody Titers and Compact Envelopes in Early Infection with Subtype C Human Immunodeficiency Virus Type 1. J. Virol., 80(11), 5211-5218.

73. Au, J.T., Kayitenkore, K., Shutes, E., Karita, E., Peters, P.J., Tichacek A., Allen, S. et al. (2006).  Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV infected individuals in Rwanda.  Journal of AIDS, 20(16), 2116-2118.

74. Khurana, S., Needham, J., Park, S., Mathieson, B., Busch, M. P., Nemo, G., et al. (2006). Novel Approach for Differential Diagnosis of HIV Infections in the Face of Vaccine-Generated Antibodies: Utility for Detection of Diverse HIV-1 Subtypes. JAIDS, 43(3), 304-312.

75. Li, M., Salazar-Gonzalez, J.F., Derdeyn, C.A., Morris, L., Williamson, C., Robinson, J.E., et al. (2006).  Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexual acquired infections in Southern Africa.  Journal of Virology, 80(23), 11776-11790.

76. Masquelier, C., Servais, J.-Y., Rusanganwa, E., Roman, F., Havuga, E., Servais, J., et al. (2007). A novel 24-base pair deletion in the coding region of CCR5 in an African population. AIDS, 21(1), 111–122.

77. Karita, E., Price, M., Hunter, E., Chomba, E., Allen, S. (2007).  Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.  Journal of AIDS, 21(4), 403- 408.

78. Rong, R., Bibollet-Ruche, F., Mulenga, J., Allen, S., Blackwell, J., Derdeyn, C. (2007).  Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection.  Journal of Virology, 81(3), 1350-1359.

79. Mendenhall, E., Muzizi, L., Stephenson, R., Chomba, E., Ahmed, Y., Haworth, A., et al. (2007).  Property grabbing and will writing in Lusaka, Zambia: an examination of wills of HIV-infected cohabiting couples.  Journal of AIDS Care, 19(3), 369-374.

80. Allen, S., Stephenson, R., Weiss, H., Karita, E., Priddy, F., Fuller, L., et al. (2007).  Pregnancy, Hormonal Contraceptive Use and HIV-related death in Rwanda.  Journal of Women’s Health, 6(7), 1017-1027.

81. Mark K.E., Meizen-Deer J., Stephenson R., Haworth A., Ahmed Y., Duncan D., Westfall A., Allen S. (2007). Contraception among HIV Concordant and Discordant Couples in Zambia: A Randomized Controlled Trial. Journal of Women’s Health. 8(16), 1200-1211.

82.  Peters PJ, Karita E, Kayitenkore K, Menzen-Derr J, Kim DJ, Tichacek A, Allen SA. (2007). HIV-infected Rwandan women have a high frequency of long-term survival. AIDS, 21 (Suppl 6):S31-S37.

83.  Lingappa JR, Lambdin B, Bukusi EA, Ngure K, Kavuma L, Inambao M, Kanweka W, Allen S, Kiarie JN, Makhema J, Were E, Manongi R, Coetzee D, de Bruyn G, Delany-Moretlwe S, Magaret A, Mugo N, Mujugira A, Ndase P, Celum C. (2008). Regional Differences in Prevalence of HIV-1 Discordance in Africa and Enrollment of HIV-1 Discordant Couples into an HIV-1 Prevention Trial. PLoS ONE 3(1): e1411. doi:10.1371/journal.pone.0001411.

84. Chomba E, Allen S, Kanweka W, Tichacek A, Cox G, Shutes E, Zulu I, Kancheya N, Sinkala M, Stephenson R, Haworth, A, and the RZHRG. (2008). Evolution of Couples’ Voluntary Counseling and Testing for HIV in Lusaka, Zambia. J Acquir Immune Defic Syndr 2008;47:108-115.

85. Kempf M, Allen S, Zulu I, Kancheya N, Stephenson R, Brill I, Tichacek A, Haworth A, Chomba E, and the RZHRG. (2008). Enrollment and Retention of HIV Discordant Couples in Lusaka, Zambia. J Acquir Immune Defic Syndr 2008;47:116-125.

86. Allen S. Karita E., Chomba E., Roth DL, Telfair J, Zulu I, Clark L, Kancheya N, Conkling M, Stephenson R, Bekan B, Kimbrell K, Dunham S, Henderson F, Sinkala M, Carael M, Haworth A. (2007). Promotion of Couples Voluntary Counseling and Testing for HIV Through Influential Networks in Two African Capital Cities. BMC Public Health 2007, 7:349 (11 Dec 2007).

87. Stephenson R., Mendenhall E., Muzizi L., Vwalika B., Chomba E., Ahmed Y., Clark L., Roth D., Telfair J., Haworth A. and Allen, S. (2008) 'The influence of motivational messages on future planning behaviors among HIV concordant positive and discordant couples in Lusaka, Zambia', AIDS Care, 20:2, 150 – 160.

88. Stephenson, R., Barker, J., Cramer, R., Hall, M. A., Karita, E., Chomba, E., Vwalika, C. and Allen, S. (2008) 'The demographic profile of sero-discordant couples enrolled in clinical research in Rwanda and Zambia', AIDS Care, 20:3, 395 – 405

89. Coldiron M, Stephenson R, Chomba E, Vwalika C, Karita E, Kayitenkore K, Tichacek A, Isanhart L, Allen S. (2007).  The relationship between alcohol consumption and unprotected sex among known HIV-discordant couples in Rwanda and Zambia. AIDS and Behavior. E-publication ahead of print, 18 August 2007

90. Rong R. Gnanakaran S. Decker JM. Bibollet-Ruche F. Taylor J. Sfakianos JN. Mokili JL. Muldoon M. Mulenga J. Allen S. Hahn BH. Shaw GM. Blackwell JL. Korber BT. Hunter E. Derdeyn CA. (2007). Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. Journal of Virology. 81(11):5658-68.

91. Crawford H. Prado JG. Leslie A. Hue S. Honeyborne I. Reddy S. van der Stok M. Mncube Z. Brander C. Rousseau C. Mullins JI. Kaslow R. Goepfert P. Allen S. Hunter E. Mulenga J. Kiepiela P. Walker BD. Goulder PJ. (2007). Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. Journal of Virology. 81(15):8346-51.

92. Brockman MA. Schneidewind A. Lahaie M. Schmidt A. Miura T. Desouza I. Ryvkin F. Derdeyn CA. Allen S. Hunter E. Mulenga J. Goepfert PA. Walker BD. Allen TM. (2007). Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. Journal of Virology. 81(22):12608-18.

93. Salazar-Gonzalez JF. Bailes E. Pham KT. Salazar MG. Guffey MB. Keele BF. Derdeyn CA. Farmer P. Hunter E. Allen S. Manigart O. Mulenga J. Anderson JA. Swanstrom R. Haynes BF. Athreya GS. Korber BT. Sharp PM. Shaw GM. Hahn BH. (2008). Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.] Journal of Virology. 82(8):3952-70.

94. Dunkle K, Stephenson R, Karita E, Chomba E, Kayitenkore K, Vwalika C, Greenberg L, Allen S. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet 2008; 371: 2183–91.

95. Stephenson R, Shutes E, Allen S, McKenna S, Brill I, Meinzen-Derr J, Kancheya N, Zulu I, Sinkala M, Tichacek A, Clark L, Haworth A and Chomba, E. The Impact of Project Closure on HIV Incidence and Mortality in a Cohort of Couples in Lusaka, Zambia. AIDS Care. 20:6, 683-691.

IN PRESS

Peters P, Zulu I, Kancheya N, Lakhi S, Chomba E, Vwalika C, Kim DJ, Brill I, Meinzen-Derr J, Tichacek A, Allen S. Modified Kigali Combined Staging Predicts Risk of Mortality in HIV infected adults in Lusaka, Zambia. Accepted to AIDS Research and Human Retroviruses.